+ All Categories

Home > Documents > KM 454e-20140905165834 - npra.gov.my · flow chart on the semi-manual submission procedure for...

KM 454e-20140905165834 - npra.gov.my · flow chart on the semi-manual submission procedure for...

Date post:	05-Aug-2019
Category:	Documents
Upload:	dinhkiet
View:	215 times
Download:	0 times

Download Report this document

Share this document with a friend

Embed Size (px):

6

Transcript

Page 1: KM 454e-20140905165834 - npra.gov.my · flow chart on the semi-manual submission procedure for generic medicines applications for registration (for scheduled and non-scheduled poisons)

Page 2: KM 454e-20140905165834 - npra.gov.my · flow chart on the semi-manual submission procedure for generic medicines applications for registration (for scheduled and non-scheduled poisons)

Page 3: KM 454e-20140905165834 - npra.gov.my · flow chart on the semi-manual submission procedure for generic medicines applications for registration (for scheduled and non-scheduled poisons)

Page 4: KM 454e-20140905165834 - npra.gov.my · flow chart on the semi-manual submission procedure for generic medicines applications for registration (for scheduled and non-scheduled poisons)

Page 5: KM 454e-20140905165834 - npra.gov.my · flow chart on the semi-manual submission procedure for generic medicines applications for registration (for scheduled and non-scheduled poisons)

Page 6: KM 454e-20140905165834 - npra.gov.my · flow chart on the semi-manual submission procedure for generic medicines applications for registration (for scheduled and non-scheduled poisons)

Recommended

KM 454e-20170605142938

KM 454e-20170824223940

KM 454e-20181024113351

KM 454e-20210811093409

KM 454e-20210120124500

KM 454e-20191008170730

KM 454e-20190429195746

KM 454e-20181005113327

KM 454e-20171110135414

KM 454e-20210907103719

KM 454e-20170824105007

KM 454e-20210813113654

KM 454e-20181025083740

KM 454e-20180430113338

KM 454e-20160106142318

KM 454e-20171213141643

KM 454e-20151207150830 - npra.gov.my · Patients should remain alert for the signs and symptoms of serious arteriothrombotic events (e.g. chest pain, shortness of breath, weakness,

KM 454e-20181211091652